Everything below concerns certificate of analysis. We keep the language plain, cite what the science says, and separate well-supported claims from open questions.
Updated 2026-04-24. Numbers and descriptions here follow the published literature rather than marketing material.
Storage conditions for research-grade SR9009 generally involve a freezer at approximately minus twenty degrees Celsius, sometimes lower for long-term preservation. Containers should remain tightly closed and protected from light. Desiccants may be used to limit moisture uptake. Solutions are often stored in aliquots to avoid repeated warming and cooling. Stability data for the compound under various conditions are limited, so laboratories typically follow supplier recommendations and verify performance through periodic analytical checks rather than assuming indefinite stability.
Identity and purity testing for SR9009 commonly uses liquid chromatography coupled with tandem mass spectrometry. This method separates the compound from matrix components and detects it by mass-to-charge transitions, providing sensitive and specific confirmation. Nuclear magnetic resonance spectroscopy can support structural identification, while high-performance liquid chromatography with ultraviolet detection may estimate purity. Because online products labeled as SR9009 may contain other substances or no active compound at all, independent verification is important in research settings. Certificates of analysis are useful but not a substitute for in-house testing.
Laboratory samples of SR9009 are typically supplied as a white to off-white powder. The compound dissolves readily in organic solvents such as dimethyl sulfoxide and ethanol, while its solubility in water is low. Because of this solubility profile, researchers often prepare concentrated stock solutions in an organic solvent before diluting them into aqueous assay buffers. Light exposure, moisture, and repeated freeze-thaw cycles can degrade many small molecules, so handling procedures usually aim to minimize these factors. Purity is commonly checked before use.
Pharmacokinetic data for SR9009 are limited in published literature. Some reports indicate low oral bioavailability and rapid clearance in animals, which complicates interpretation of exposure and effect. Researchers often use injected routes in preclinical work to achieve measurable systemic levels. Analytical studies rely on mass spectrometry to detect the parent compound and its metabolites. Questions about tissue distribution, active metabolites, and long-term consequences remain open. Species differences in metabolism can affect observed half-life and target engagement.
SR9009 is a synthetic small molecule studied as an agonist of the nuclear receptors REV-ERBα and REV-ERBβ. These receptors help regulate circadian rhythms and metabolic gene expression. In laboratory experiments, SR9009 binds these receptors and alters transcription of genes involved in lipid handling, glucose metabolism, and mitochondrial function. It is not a naturally occurring compound and has no approved therapeutic use. Research interest stems from its ability to modify energy metabolism in cells and animal models.
| Property | Value | Notes |
|---|---|---|
| Appearance | White to off-white powder | Typical for research-grade material |
| Solubility | Soluble in DMSO and ethanol; low aqueous solubility | Organic stock solutions are common |
| Typical storage temperature | -20 °C or lower | Protect from light and moisture |
| Common analytical method | LC-MS/MS | Used for detection and confirmation |
| Common synonyms | SR9009; Stenabolic | Stenabolic is an informal name |
SR9009 stability depends on temperature, moisture, light, and solvent. Solid material is generally kept cool and dry, while solutions may require protection from repeated warming and cooling. Degradation can appear as color changes, precipitate, or new chromatographic peaks. Researchers should follow supplier instructions and their own stability data. Long-term storage conditions for human use have not been established because the compound lacks approved clinical formulation.
SR9009 is supplied as a solid research chemical, often in milligram quantities. Laboratories typically weigh it in a controlled environment because fine powders can disperse. Stock solutions are commonly prepared in dimethyl sulfoxide and stored in small aliquots to reduce freeze-thaw cycles. Personal protective equipment and chemical fume hoods are standard when handling unknown or potent compounds. These practices address laboratory safety rather than human use.
Detection in biological samples can be complicated by rapid metabolism and low circulating concentrations. Some studies report phase I and phase II metabolites, and analytical methods may need to target those species in addition to the parent compound. Immunoassays are not broadly available, so mass spectrometry remains the main confirmatory approach. For anti-doping testing, laboratories look for SR9009 and its metabolites using validated LC-MS methods. Open questions include how long metabolites remain detectable and how different routes of administration alter detection windows.
In laboratory settings, SR9009 is typically characterized by liquid chromatography–mass spectrometry (LC-MS) or high-performance liquid chromatography with ultraviolet detection (HPLC-UV). These methods can confirm identity and estimate purity, but they require reference standards for accurate quantification. Because SR9009 is not a licensed pharmaceutical, no harmonized pharmacopeial monograph exists. Laboratories often validate in-house methods for matrices such as plasma, urine, or cell culture media. Sample preparation may involve protein precipitation or liquid-liquid extraction before analysis.
Physicochemical behavior influences handling. SR9009 is described as a solid with limited aqueous solubility, so organic solvents such as dimethyl sulfoxide or ethanol are common in research stock solutions. Aqueous dilution can produce precipitates if the organic content is too low. Light, heat, and repeated freeze-thaw cycles may affect stability. Storage recommendations usually specify a desiccated freezer environment protected from light, but exact stability data depend on the formulation and matrix.
REV-ERB proteins help regulate daily cycles in gene expression, including genes tied to lipid and glucose metabolism. SR9009 binds these receptors and alters their activity in cell and animal experiments. Consequences observed in rodents include changes in skeletal muscle oxidative capacity, blood lipid levels, and exercise performance. The precise chain from receptor occupancy to whole-body effects is still an active area of study. Human responses cannot be assumed from rodent data.
Most published work on SR9009 consists of preclinical studies. It is widely sold as a research chemical, a category that does not imply safety, efficacy, or pharmaceutical-grade quality. Sports anti-doping organizations have listed SR9009 as a prohibited substance, and its presence in an athlete sample can lead to sanctions. Legal status differs by country; in several jurisdictions it is not approved for human consumption and may be treated as an unapproved new drug.
SR9009 is a synthetic small molecule studied as an agonist of the nuclear receptors REV-ERBα and REV-ERBβ. It is not a steroid, peptide, or natural hormone. In scientific literature, it appears under the code SR9009 and in non-scientific contexts as Stenabolic. The compound was identified through chemical screening efforts aimed at targeting circadian clock components. Its status remains investigational, and no regulatory agency has approved it as a human medicine.
SR9009 is often grouped with compounds studied for circadian and metabolic regulation rather than with classical anabolic steroids. Its interactions with nuclear receptors differ from those of androgen receptor ligands, and its proposed mechanisms involve transcriptional control rather than direct hormone signaling. Some sources classify it as a metabolic modulator because of observed effects on energy utilization. The distinction matters for regulation and for interpreting research results across different compound classes.
SR9009 is a synthetic small molecule developed as a REV-ERB agonist. It binds to REV-ERBα and REV-ERBβ, nuclear receptors that help regulate circadian rhythms and metabolic gene expression. In cell and animal studies, the compound alters lipid and glucose handling and influences skeletal muscle oxidative capacity. Its exact effects in humans remain largely uncharacterized because controlled clinical trials have not been reported. The molecule is frequently described in preclinical literature as a metabolic modulator.
=== Cancer === HLA-G has been shown to be associated with tumor escape in cancers, because it causes the immune system to not pay attention to cancer cells. Because it is upregulated in cancer cells, it could serve as a potential target for immunotherapy. Monoclonal antibodies that bind to HLA-G have been used successfully against cancers as part of a strategy to inhibit immune checkpoints. HLA-G has potential utility as a tumor marker due to the large increase in HLA-G in many cancers, including breast cancer, ovarian cancer, and lung cancer. Increased expression of HLA-G has been associated with the metastatic potential of tumor cells.
== Toxicity == DBNPA exhibits various degrees of toxicity like acute oral toxicity, dermal toxicity and inhalation toxicity while it is stable under normal conditions of use. Contact with strong amines should however be avoided including bases, oxidizing agents and reducing agents. DBNPA is corrosive to mild steel, iron and aluminum. The creation of dust when handling DBNPA should be avoided and precautionary measures against electrostatic discharges should be taken. Avoid heat, open flames and other potential sources of ignition when handling DBNPA. Additionally, DBNPA is corrosive to the eyes. It is moderately toxic by oral or inhalation routes and slightly toxic by the dermal route. DBNPA can kill skin tissue in rabbits when administered at high doses for a prolonged period of time. DBNPA is also a skin sensitizer. In a toxicity study using rats, DBNPA caused breathing difficulty associated with lung or heart disease, as well as weight loss and several deaths at higher doses. When applied to the skin of rats in another study, DBNPA caused changes in body chemistry and dermal irritation at the higher doses. DBNPA is a developmental toxicant in rabbits. It was shown to cause structural alterations (retarded ossification of several fetal skeleton elements) at a maternally non-toxic dose level. DBNPA is not mutagenic. The United States Environmental Protection Agency (EPA) has received several human incident reports in which eye, throat and respiratory irritation, runny nose and headache resulted from spills or misuse of DBNPA.
==== Saddam Hussein ==== In July 2007, the New Statesman printed selected portions of a 1976 piece by Hitchens which they claimed "took a more admiring view of the Iraqi dictator" than his later strong support for ousting Saddam Hussein. In this Hitchens pointed to Iraq's military strength, oil reserves and young leadership to argue that Iraq was "a force to be reckoned with" and described Saddam Hussein as a leader "who has sprung from being an underground revolutionary gunman to perhaps the first visionary Arab statesman since Nasser." He also argued:
Southern Ohio Medical Center (or SOMC) is a 216-bed 501(C)(3) not-for-profit hospital in Portsmouth, Ohio. It provides emergency and surgical care, as well as other health care services. SOMC employs 2,600 full-time employees and part-time employees, has a medical staff of more than 140 physicians and specialists, and is supported by approximately 800 volunteers. In 2020, Fortune magazine ranked Southern Ohio Medical Center at number 22 of their Fortune List of the Top 100 Companies to Work For based on an employee survey of satisfaction.
As of 2009, 8 Prizes have been awarded for contributions in the field of signal transduction by G proteins and second messengers, 13 have been awarded for contributions in the field of neurobiology and 13 have been awarded for contributions in intermediary metabolism. In 1939 Gerhard Domagk, a German, was not allowed by his government to accept the prize. He later received a medal and diploma, but not the money. As of 2024, the prize has been awarded to 229 individuals, thirteen of them were women (Gerty Cori being the first to be awarded in 1947). There have been nine years in which the Nobel Prize in Physiology or Medicine was not awarded (1915–1918, 1921, 1925, 1940–1942). There were also five years for which the Nobel Prize in Physiology or Medicine was delayed for one year. The Prize was not awarded in 1914, as the Nobel Committee for Physiology or Medicine decided that none of that year's nominations met the necessary criteria, but was awarded to Robert Bárány in 1915 and counted as the 1914 prize. This precedent was followed for the 1922 prize awarded to Archibald Hill and Otto Fritz Meyerhof in 1923, the 1926 prize awarded to Johannes Fibiger in 1927, the 1938 prize awarded to Corneille Heymans in 1939, and the 1943 prize awarded to Henrik Dam and Edward Adelbert Doisy in 1944.
Sources: en.wikipedia.org
== Outcomes == The primary measures of weight loss outcomes for endoscopic bariatric therapies include total body weight loss (percentage of pre-procedure weight lost by a certain time point) and excess weight loss (percentage of pre-procedure weight above ideal body weight that is lost by a certain time point). The Preservation and Incorporation of Valuable Endoscopic Innovation thresholds is an expert panel with gastroenterologists and surgeons from the American Society for Gastrointestinal Endoscopy and The American Society for Metabolic and Bariatric Surgery, and in 2015, this panel recommended that any new endoscopic therapy for weight loss should have an excess weight loss exceeding 25% and a serious adverse event rate less than 5%. Total body weight loss thresholds were not defined but are generally considered meaningful in novel endoscopic bariatric therapies if exceeding 5%. Multiple studies of ESG have shown that this therapy satisfies these criteria, as outlined below.
== X == X-chromosome inactivation A process in female mammals where one of the two X chromosomes is randomly silenced in each cell to balance gene dosage with males. Some neurological disorders, such as Rett syndrome, are influenced by X-inactivation patterns. X-linked adrenoleukodystrophy A genetic disorder affecting the breakdown of very-long-chain fatty acids, leading to their accumulation in the brain and adrenal glands. It causes progressive demyelination and adrenal insufficiency. X-linked intellectual disability A group of inherited cognitive disorders associated with mutations on the X chromosome. Examples include Fragile X syndrome and MECP2 duplication syndrome. Xenon (anesthetic) A noble gas with neuroprotective and anesthetic properties. It has been studied for its NMDA receptor antagonism and minimal side effects on brain function. Xenotransplantation The transplantation of cells or tissues from one species to another for research or therapeutic purposes. In neuroscience, fetal pig or rat neural cells may be studied in primate models to investigate brain repair. Xerostomia A condition of dry mouth that may result from neurological disorders affecting autonomic control of salivary glands, such as Parkinson's disease or side effects of anticholinergic drugs.
The industry was expected to invest US$7.1 billion in integrated resorts (US$3.5 billion in Marina Bay; US$3.6 billion in Resorts World). In 2008, the CRA was formed to regulate gambling in management and operation of the casinos in Singapore. It was reconstituted to form the GRA in 2022. On 20 July 2017, the Ministry of Home Affairs announced that regulations on slot machines would be tightened over the next two years and included changes that added more stringent criteria to meet for permits, requirements aimed at reducing availability and accessibility, and setting in place social safeguards to mitigate potential problem gambling. In 2018, the newly formed Singapore Premier League (SPL), known previously as S.League, disallowed non-SPL clubs to have slot machines while SPL clubs to have a maximum of 15 machines, by the end of 2019. On 15 September 2022, SPL clubs were informed to stop all jackpot operations by the end of October.
== Diagnosis == Kwashiorkor, or edematous malnutrition, like many other malnutrition diseases, is indirectly assessed using anthropometry. Kwashiorkor is a subtype of severe acute malnutrition (SAM) characterized by bilateral peripheral pitting edema. According to the World Health Organization, the SAM diagnosis parameters are a "mid-upper arm circumference (MUAC) of < 115 mm, weight-for-height/length Z-score (WHZ) of < -3Z and nutritional edema or any combination of these parameters." Additional clinical findings on physical exam include marked muscle atrophy, abdominal distension, dermatitis, and hepatomegaly. WHO criteria for clinical assessment of malnutrition are based on the degree of wasting (MUAC), stunting (weight-for-height Z-score), and the presence of edema (mild to severe). In addition to anthropometric measures, laboratory tests can be critical for diagnosing kwashiorkor. Low serum albumin levels (hypoalbuminemia) are a hallmark of protein deficiency, and elevated liver enzymes may indicate liver dysfunction. Electrolyte imbalances and blood tests may also be used to assess the degree of organ involvement and complications. Specifically in children, severe malnutrition, such as kwashiorkor, can lead to notable changes in brain function and behavior. Children with kwashiorkor tend to be irritable and may develop cerebral atrophy, whereas those with severe wasting frequently show apathy, reduced movement, and speech delays. These neurological and behavioral changes are key factors in the clinical assessment of malnutrition.
=== Urinary incontinence === Serotonin plays a key role in mechanisms involved in micturition and continence. Many potent compounds with high selectivity for 5-HT2C receptors have been synthesized and are promising candidates for further development for the treatment of stress urinary incontinence (SUI).
Sources: en.wikipedia.org
The British had no answer to the V-2 rocket bombardment that began in September 1944. The missiles flew too high and too fast to be detected during their approach, leaving no time even for an air raid warning to be sounded. Their supersonic speed meant that the explosions occurred without warning before the sound of their approach reached the target. The government initially tried to pass them off as explosions in the underground gas mains. It was clear this was not the case, and eventually, examples of the V-2 falling in its final plunge were captured on film. In response, several CH stations were re-organized into the "Big Ben" system to report the V-2s during launch. No attempt was made to try to find the location of the launch; the radio-goniometer was simply too slow to use. Instead, each of the stations in the network, Bawdsey, Gt. Bromley, High St, Dunkirk and Swingate (Dover) were left set to their maximum range settings and in the altitude measuring mode. In this mode, the radar had several stacked lobes where they were sensitive to signals. As the missile ascended it would pass through these lobes in turn, causing a series of blips to fade in and out over time. The stations attempted to measure the ranges to the target as they flew through each of these lobes and forwarded that by telephone to a central plotting station. At the station, these range measurements were plotted as arcs on a chart, known as range cuts. The intersections of the arcs defined the approximate area of the launcher.
In number theory, the crank of a partition is a certain integer associated with the partition. Dyson first introduced the term without a definition in a 1944 paper in a journal published by the Mathematics Society of Cambridge University. He then gave a list of properties this yet-to-be-defined quantity should have. In 1988, George E. Andrews and Frank Garvan discovered a definition for the crank satisfying the properties Dyson had hypothesized.
Besides inhibiting human acetylcholinesterase (although to a lesser degree than the insect enzyme), carbamate insecticides also target human melatonin receptors. The human health effects of carbamates are well documented in the list of known endocrine disruptor compounds. Clinical effects of carbamate exposure can vary from slightly toxic to highly toxic depending on a variety of factors including such as dose and route of exposure with ingestion and inhalation resulting in the most rapid clinical effects. These clinical manifestations of carbamate intoxication are muscarinic signs, nicotinic signs, and in rare cases central nervous system signs.
=== Usman Abboud === Usman Abboud (Amir El-Masry) is the assistant to Kaspar Zenden, Clement's sole client. Usman puts on a professional facade for Kaspar, pretending to be conservative and abstinent from alcohol and drugs, but reveals himself as a hard-partying, homosexual playboy to Robert and later Greg. After Clement is fired from Pierpoint, Usman tells Robert that Kaspar no longer wishes to continue his relationship with Pierpoint.
== Uses == Decor, candle – Chemicals detected in substances or products (note that these chemicals may be absent from an 'ingredient list' for the product and thus unexpected, but have been detected in product testing studies) Fragrance – Fragrances or odor agents, can be used in home products (cleaners, laundry products, air fresheners) or similar industrial products; usage indicated when known; more specific modifiers included when known.
Sources: en.wikipedia.org
Research-grade SR9009 is typically stored frozen at about minus twenty degrees Celsius, protected from light and moisture. Stock solutions are often kept in aliquots to avoid repeated freeze-thaw cycles. Specific storage conditions should follow the supplier's documentation.
Liquid chromatography with tandem mass spectrometry is widely used to detect and confirm SR9009 in laboratory samples. The technique offers high sensitivity and can distinguish the target compound from related substances. Nuclear magnetic resonance and ultraviolet detection may support identity and purity checks.
Online products labeled as SR9009 may vary in identity, purity, and actual content. Independent testing helps confirm that a sample matches its label and does not contain unexpected contaminants. This is important for reproducible research and for interpreting experimental results.
It is a synthetic research compound that activates REV-ERB nuclear receptors. It is not an approved drug or dietary supplement. Most information comes from cell and animal studies.